Brook statement on self-injectable contraceptive

Published: 24 September 2015

In response to the news that the injectable contraceptive Sayana has been approved for self-injection following instruction from a healthcare professional, Sue Burchill, Brook's Head of Nursing said:

"We're really pleased to see a new way to administer a long acting reversible contraceptive (LARC) become available. LARCs are popular with many people as they fit with their lifestyles; they're also really cost effective, so it's great to see innovation which will expand the range of choices on offer.

"Brook always advises anyone using a LARC to use barrier methods of contraception, such as condoms and dental dams, in order to protect against sexually transmitted infections."

For media enquiries please contact Brook's press office on 07789 682831 or email press@brook.org.uk

Notes to editors

Brook believes that young people should have access to great sexual health services and wellbeing support.

Brook provides free and confidential sexual health information, contraception, pregnancy testing, advice and counselling, testing and treatment for sexually transmitted infections and education programmes, reaching nearly 235,000 young people nationwide every year.
 
Read our Strategic Plan 2017-2020 and learn more about the difference we make in our latest Success Report.